NK Cells

NK Cell Infusion is an advanced immune-cell therapy designed to support the body’s natural defense system. Natural Killer cells are specialized white blood cells that help identify and eliminate abnormal cells, including virus-infected and tumor-related cells. Through a controlled medical process, NK cells may be collected, activated, expanded, and infused back into the body to support immune surveillance and overall resilience. The U.S. National Cancer Institute defines NK cells as immune cells with enzyme-containing granules that can kill tumor cells or virus-infected cells.

At Mr. Chai Ozone Clinic, NK Cell Infusion should begin with a doctor-led consultation to assess each patient’s health status, goals, and suitability. This therapy is best positioned as personalized immune support, not a replacement for standard medical or oncology care.
Potential health benefits

1. Immune surveillance support

NK cells are part of the innate immune system. Their natural role is to detect and eliminate abnormal cells early, especially virus-infected cells and some tumor cells. This is the strongest biological rationale behind NK infusion.

2. Cancer immunotherapy potential

The most serious research around NK cell therapy is in oncology, especially blood cancers and solid tumors. A 2024 systematic review of NK therapy in solid tumors found promising response signals and generally favorable safety, but also concluded that more research is needed before NK therapy can be fully integrated into standard cancer treatment.

3. Possible lower toxicity than some T-cell therapies

NK-based therapies are being explored partly because they may have a lower risk of severe cytokine release syndrome, neurotoxicity, and graft-versus-host disease compared with some T-cell approaches. That said, “lower risk” does not mean “no risk.”

4. Combination potential with antibodies and other therapies

NK cells can work through ADCC, meaning they can attack cells that have been marked by antibodies. This is why NK infusions are often studied alongside monoclonal antibodies or other cancer therapies, not only as a standalone treatment.

Who fits the most

Best-fit audience, from a medical-evidence perspective:

People who may be most relevant for NK Cell Infusion are those seeking doctor-supervised immune-cell therapy, especially:

  • 1. Patients exploring adjunctive cancer immunotherapy under oncology guidance.
  • 2. Patients with certain cancers where NK therapy is being studied, such as liver cancer, blood cancers, lung cancer, breast cancer, ovarian cancer, pancreatic cancer, and colorectal cancer.
  • 3. Individuals with documented immune concerns who have been medically screened and are not expecting a guaranteed cure.
  • 4. Wellness clients who want immune-support consultation, provided the clinic avoids disease-treatment claims unless backed by physician diagnosis and regulatory approval.

Not ideal or needs extra caution:

  • 1. Cancer patients who want NK infusion as a replacement for standard oncology care.
  • 2. Pregnant or breastfeeding patients.
  • 3. People with uncontrolled active infection.
  • 4. People with uncontrolled autoimmune disease.
  • 5. Patients on strong immunosuppressive medication.
  • 6. Patients with severe uncontrolled heart, liver, kidney, or blood disorders.